Developing Intelligent Wearable Algorithms
Launched by LINNAEUS UNIVERSITY · Dec 5, 2023
Trial Information
Current as of July 21, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Globally, the life expectancy is gradually increasing, which leads to a demographic shift towards an increasing proportion of older people. For example, in Sweden, the number of individuals over the age of 75 will double during the next 50 years and the proportion will increase by more than 60% (Statistics Sweden, publicly available data). This means that more people will live longer and less people will be available to care for them. One of our major societal challenges to meet this demographic transition is to develop strategies for maintaining good health and quality of life in that age ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Being able to jog for 30 consecutive minutes
- Exclusion Criteria:
- • Known heart condition
About Linnaeus University
Linnaeus University is a prominent academic institution in Sweden, dedicated to advancing knowledge and innovation through rigorous research and education. As a clinical trial sponsor, the university leverages its interdisciplinary expertise to conduct high-quality research that addresses critical health challenges. With a commitment to ethical standards and participant safety, Linnaeus University fosters collaboration among researchers, healthcare professionals, and industry partners, aiming to translate scientific discoveries into practical solutions that enhance patient care and improve health outcomes. Through its clinical trials, the university contributes to the global body of medical knowledge and supports the development of new therapeutic strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kalmar, Kalmar Lan, Sweden
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported